Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of SGLT2 Inhibitors on Cognitive Functions and a Neuroinflammatory Biomarker, Brain-Derived Neurotrophic Factor Levels in Patients With Type 2 Diabetes

NCT05341388 is registered in ClinicalTrials.gov with Goztepe Training and Research Hospital as lead sponsor.

NCT NCT05341388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05341388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of SGLT2 Inhibitors on Cognitive Functions and a Neuroinflammatory Biomarker, Brain-Derived Neurotrophic Factor Levels in Patients With Type 2 Diabetes
Lead sponsor
Goztepe Training and Research Hospital
Phase
Observational
Overall status
Terminated
Start date
March 1, 2021
Completion date
November 30, 2021
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, type2 diabetes